Quentin Massé, auteur sur Theradiag

23/09/2020: 2020 Half-year financial report publication (only available in french)

Post author:Quentin Massé
Post published:23 September 2020
Post category:Press Releases

Croissy-Beaubourg, September 23, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that its half-year financial report as at 30 June 2020 has been…

Presentation of the 2020 half-year results (only available in french) – 2020, 22nd September

Post author:Quentin Massé
Post published:22 September 2020
Post category:Financial presentations

Theradiag will hold a conference call to present H1 2020 results at 9:00am on September 22. To take part, please dial +33 1 72 72 74 03 followed by participant PIN code 24 52 93…

21/09/2020: French company Theradiag launches an antigen test in France to detect COVID-19 in less than 15 minutes

Post author:Quentin Massé
Post published:21 September 2020
Post category:Press Releases

Croissy-Beaubourg (77), September 21, 2020, 5:45 pm CEST - Theradiag, a French company specializing in diagnostic tests for autoimmune and infectious diseases, today announces the market launch of a CE-marked antigen test for detecting COVID-19.On…

23/09/2020: 2020 Half-year financial report publication (only available in french)

Presentation of the 2020 half-year results (only available in french) – 2020, 22nd September

21/09/2020: French company Theradiag launches an antigen test in France to detect COVID-19 in less than 15 minutes

“14es Assises Nationales des MICI”

XXVIIIème Séminaire Interne des CECOS

JFHOD 2021